June 2020 Notable News
It’s officially summer so grab a cup of coffee and soak up some vitamin D because this month we learn that both of those things can help prevent cancer. We also learn about the recall of a popular drug and the approval of some others. In addition, there’s a new blood test to diagnose liver cancer and some tips on how to recognize skin cancer. Finally, research shows that COVID-19 remains a very real threat, especially for cancer patients.
Vitamin D and Coffee Benefits
With so much going on, your vitamin D status may not be on your mind, but you might want to give it some thought, reports sciencedaily.com. It turns out that a good vitamin D status is good for cancer prevention and prognosis, especially for colon and blood cancers like leukemia and lymphoma. Conversely, a low vitamin D status often correlates with higher incidence of cancer and lower survival rates. You can learn more about vitamin D and cancer here.
While you’re out soaking up the vitamin D from the sun’s rays, you might want to bring your favorite cup of coffee because there’s evidence that coffee could reduce the risk of cancer, reports dailycoffeenews.com. The news comes from an update in the diet activity guidelines from the American Cancer Society. It’s not known how or why coffee seems to help prevent several types of cancers, but there’s been a decade of research that supports the claim. In addition to coffee, the American Cancer Society recommends following a healthy diet, limiting alcohol, staying active, and maintaining a healthy weight. Research shows that diet and exercise lifestyle choices are connected to 18 percent of all cancer cases in the United States. Learn more about coffee and cancer here.
Take a Look at Your Skin
All this talk about sun exposure makes it a good time to think about skin cancer. Especially since there’s room for improvement in skin cancer survival rates, says consumerreports.org. Getting to know your own skin could be the key to survival. A Consumer Reports survey found that only 52 percent of Americans have their skin regularly checked by a doctor. There’s debate about whether or not everyone should see a dermatologist every year, but early detection of skin cancer makes a big difference. When skin cancer is found early treatment is relatively non-invasive and early stage melanoma has a 98 percent survival rate. So, whether you see a doctor or not, you should perform monthly skin checks of your own. Get familiar with the moles and marks on your skin and look for any that don’t seem to fit in. If you find something that looks irregular, let your doctor know. Learn more and find examples of what skin cancer looks like here.
Metformin Hydrochloride Recall
While you’re checking your skin, you might also need to check your list of medications. A popular diabetes drug has been recalled due to cancer risk, reports webmd.com. All lots of metformin hydrochloride extended release 500 mg tablets were recalled due to the possibility that they contained high levels of N-Nitrosodimethylamine (NDMA) which is a chemical thought to cause cancer. A test by the United States Food and Drug Administration (FDA) found higher than allowed levels of NDMA in one lot of metformin. Get more information about the recall here.
FDA Expands Indication for Gardasil 9
The FDA has given accelerated approval for the use of a vaccine to prevent head and neck cancers, reports statnews.com. The human papilloma virus (HPV) vaccine, Gardasil 9, is recommended for both males and females ages 9 through 45 to prevent several cancers. However, the vaccine was not previously recommended as prevention for head and neck cancers even though they are commonly caused by HPV in the United States. The hope is that, by including head and neck cancers in the list of cancers the vaccine prevents, it will raise awareness for and help prevent the occurrence of these types of cancers. Find more about Gardasil here.
Good News for Thyroid and Non-Small Cell Lung Cancer
The FDA has also given accelerated approval for a drug to treat thyroid and lung cancer, says cancer.gov. The drug selpercatinib (Retevmo) will treat people with thyroid or non-small cell lung cancer with tumors that have a gene alteration called RET. The drug blocks the RET proteins and was shown to shrink tumors. Selpercatinib has fewer side effects than older RET blocking drugs. Accelerated approval means that, although the drug has not gone through all required levels of testing, it can be approved for use, but testing must continue while the product is on the market. The process is only used for drugs that treat serious or life-threatening diseases without better treatment options. Learn more about the accelerated approval of selpercatinib here.
There’s another drug of note this month giving hope to advanced cancer patients who have nausea and vomiting, says cancer.gov. In a study conducted by the National Cancer Institute the drug olanzapine (Zyprexa) was found to reduce nausea and vomiting in advanced cancer patients. Olanzapine is an antipsychotic medication mainly used to treat bipolar disorder and schizophrenia and has also been used off-label to prevent nausea and vomiting in cancer patients. Learn more here.
Detecting Liver Cancer
The National Cancer Institute was also involved in a study where a blood test has been developed to determine which people are most likely to develop liver cancer, says cancer.gov. The simple blood test is used to check for exposure to certain viruses that lead to the development of hepatocellular carcinoma (HCC) which is the most common form of liver cancer. The test could help lead to early diagnosis and treatment. Most patients with HCC are diagnosed when the cancer is advanced and incurable, but when caught early the prognosis is much better. With HCC on the rise in the US, a test that could help with early detection is welcome news. Learn more about the testing here.
The not-so-welcome news continues about the novel coronavirus. There are some new studies that emphasize the danger of the coronavirus for cancer patients, reports apnews.com. The studies showed that current and former cancer patients who developed COVID-19 were more likely to die within a month than people without cancer. One study showed that 13 percent of cancer patients with COVID-19 died. Another study found the death rate to be 28 percent. The studies are a reminder of how critical it is for cancer patients to do all they can to follow safety guidelines so they can avoid contracting the virus. Find out more here.
Jennifer Lessinger is a professional writer and editor who learned the value of patient empowerment during her struggle with a hard-to-diagnose and complex endocrine disorder.